Form 6-K Galmed Pharmaceuticals For: Nov 09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St set for higher open as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Galmed Pharma (GLMD) Tops Q3 EPS by 6c
November 9, 2015 9:35 AM ESTGalmed Pharma (NASDAQ: GLMD) reported Q3 EPS of ($0.23), $0.06 better than the analyst estimate of ($0.29).
For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.
... More